TY  - JOUR
AU  - Jack Cuzick
AU  - Dowsett, Mitch
AU  - Pineda Sanjuan, Silvia
AU  - Wale, Christopher
AU  - Salter, Janine
AU  - Quinn, Emma
AU  - Zabaglo, Lila
AU  - Mallon, Elizabeth
AU  - Green, Andrew
AU  - Ellis, Ian 
AU  - Howell, Anthony
AU  - Buzdar, Aman 
AU  - Forbes, John F.
PY  - 2011
DO  - 10.1200/JCO.2010.31.2835
SN  - 0732-183X
UR  - https://hdl.handle.net/20.500.14352/97357
T2  - Journal of Clinical Oncology
AB  - Purpose: We recently reported that the mRNA-based, 21-gene Genomic Health recurrence score (GHI-RS) provided additional prognostic information regarding distant recurrence beyond that obtained from classical clinicopathologic factors (age, nodal...
LA  - eng
M2  - 4273
PB  - ASCO
KW  - Epidermal growth factor receptor 2
KW  - Estrogen receptor
KW  - Ki 67 antigen
KW  - Progesterone receptor
KW  - Breast cancer
KW  - Cancer adjuvant therapy
KW  - Cohort analysis
KW  - Genomic Health Recurrence score
KW  - Histopathology
KW  - Immunohistochemistry
KW  - Proportional hazards model
TI  - Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer
TY  - journal article
VL  - 29
ER  -